Lee S. Schwartzberg
Renown Health(US)
Publications by Year
Research Areas
Cancer Treatment and Pharmacology, Advanced Breast Cancer Therapies, Nausea and vomiting management, HER2/EGFR in Cancer Research, Breast Cancer Treatment Studies
Most-Cited Works
- → 2006 Update of Recommendations for the Use of White Blood Cell Growth Factors: An Evidence-Based Clinical Practice Guideline(2006)1,639 cited
- → Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology(2018)1,614 cited
- → PEAK: A Randomized, Multicenter Phase II Study of Panitumumab Plus Modified Fluorouracil, Leucovorin, and Oxaliplatin (mFOLFOX6) or Bevacizumab Plus mFOLFOX6 in Patients With Previously Untreated, Unresectable, Wild-Type KRAS Exon 2 Metastatic Colorectal Cancer(2014)627 cited
- → Safety and Efficacy of Oxaliplatin and Fluoropyrimidine Regimens With or Without Bevacizumab As First-Line Treatment of Metastatic Colorectal Cancer: Results of the TREE Study(2008)621 cited
- → An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy(1995)619 cited
- → NCCN Guidelines Insights: Breast Cancer, Version 1.2017